Page 1 of Clinical Trials for "Multiple Sclerosis, Relapsing-Remitting", 247 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
BG00012 Phase 2 Combination Study in Subjects With Multiple Sclerosis
Last Updated: May 10, 2012
Condition(s): Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis, Relapsing-remitting; Multiple Sclerosis
2
Terminated
Minocycline as add-on to Interferon Beta-1a (Rebif®) in Relapsing Remitting Multiple Sclerosis
Last Updated: July 14, 2011
Condition(s): Multiple Sclerosis, Relapsing-Remitting
3
Recruiting
An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters
Last Updated: January 19, 2012
Condition(s): Multiple Sclerosis, Relapsing-Remitting
4
Completed
A Study to Evaluate Rebif® New Formulation (IFN-beta-1a) in Relapsing Remitting Multiple Sclerosis
Last Updated: May 27, 2010
Condition(s): Multiple Sclerosis, Relapsing-Remitting
5
Active, not recruiting
A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
Last Updated: July 13, 2009
Condition(s): Multiple Sclerosis, Relapsing-Remitting
6
Active, not recruiting
Safety and Efficacy Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
Last Updated: July 14, 2011
Condition(s): Multiple Sclerosis, Relapsing-remitting
7
Recruiting
Melatonin in Relapsing-Remitting Multiple Sclerosis Patients
Last Updated: July 25, 2011
Condition(s): Multiple Sclerosis, Relapsing-Remitting
8
Completed
CLARITY - Safety and Efficacy of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (MS)
Last Updated: January 27, 2012
Condition(s): Multiple Sclerosis, Relapsing-Remitting
9
Withdrawn
QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea
Last Updated: April 12, 2012
Condition(s): Multiple Sclerosis, Relapsing-Remitting
10
Completed
A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-Remitting Multiple Sclerosis (MS)
Last Updated: March 21, 2009
Condition(s): Multiple Sclerosis, Relapsing-Remitting
11
Completed
Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis
Last Updated: March 11, 2011
Condition(s): Multiple Sclerosis, Relapsing-Remitting
12
Active, not recruiting
Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®
Last Updated: September 30, 2011
Condition(s): Multiple Sclerosis, Relapsing-Remitting
13
Completed
Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Last Updated: June 15, 2009
Condition(s): Multiple Sclerosis, Relapsing-Remitting
14
Recruiting
A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
Last Updated: April 12, 2012
Condition(s): Multiple Sclerosis, Relapsing-Remitting
15
Active, not recruiting
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
Last Updated: November 22, 2011
Condition(s): Relapsing Remitting Multiple Sclerosis; Autoimmune Diseases; Immune System Diseases; Nervous System Diseases; Autoimmune Diseases of the Nervous System
16
Completed
Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
Last Updated: April 7, 2011
Condition(s): Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
17
Active, not recruiting
A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo
Last Updated: April 10, 2012
Condition(s): Relapsing Remitting Multiple Sclerosis
18
Recruiting
A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects
Last Updated: January 23, 2012
Condition(s): Relapsing Remitting Multiple Sclerosis (RRMS)
19
Recruiting
Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod
Last Updated: December 22, 2011
Condition(s): Relapsing Remitting Multiple Sclerosis (RRMS)
20
Active, not recruiting
A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients "TIMER" Study
Last Updated: February 9, 2012
Condition(s): Relapsing Remitting Multiple Sclerosis (RRMS)

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Multiple+Sclerosis%2C+Relapsing-Remitting%22

Page 1 of Clinical Trials for "Multiple Sclerosis, Relapsing-Remitting", 247 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About